JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
90 hedge funds and large institutions have $180M invested in Jounce Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 32 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
9% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 32
Holders
90
Holding in Top 10
2
Calls
$639K
Puts
$128K
Top Buyers
| 1 | +$2.84M | |
| 2 | +$1.74M | |
| 3 | +$1.59M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$876K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$491K |
Top Sellers
| 1 | -$2.03M | |
| 2 | -$1.4M | |
| 3 | -$1.18M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.16M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$872K |